Cancer-related genetic and genomic testing (CGT) is changing cancer care by personalizing
care options, leading to an era of precision medicine. Advances in and increased use of …

Effective use of genetic and genomic data in cancer prevention and treatment depends on
adequate communication with patients and the public. Although relevant empirical work has …

As genetics and genomics become part of mainstream Medicine, these advances have the
potential to reduce or exacerbate health disparities. Gaps in effective communication (where …

Cancer‐related genetic testing (hereafter CGT) has transformed cancer prevention,
treatment, and care. Researchers debate whether diffusion and use of genetic testing will …

Background Despite decades of effort to reduce racial cancer disparities, Black people
continue to die at higher rates from cancer than any other US racial group. Because …

Advances in the application of genomic technologies in clinical care have the potential to
increase existing healthcare disparities. Studies have consistently shown that only a fraction …

Abstract Background Primary care providers (PCPs) can play a critical role in helping
patients receive the preventive health benefits of cancer genetic risk information. Thus, the …

Background Studies have consistently indicated that the majority of individuals meeting the
US Prevention Services Task Force guidelines for genetic testing have not had genetic …

Communicating risk and other health information in a clear, understandable, and actionable
manner is critical for the prevention and control of cancer, as well as the care of affected …

Effective communication, where all parties share a common understanding, is necessary to
realize the promise of Genomic Medicine. It is especially salient given the imperative to …